We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Information for patients, healthcare professionals and developers of new medicines
Foresight project looking at how future scientific advances may affect our understanding of addiction and drug use.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regulations. ACMD is an advisory non-departmental...
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
This series brings together all documents relating to ACMD drug-specific reports.
Check what side effects people have reported when they've taken a medicine.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Guidance on applications and licences for manufacturers & wholesalers, suspended and revoked licences, registrations, exporting medicines, defective medicinal products and fees.
Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor, the Commission on Human Medicines
Information about new applications, post-licensing, advertising, product information and fees.
This essential guide for drug and treatment professionals provides the most up to date scientific evidence on the health harms arising from drug misuse.
How veterinary medicines can be advertised.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Controlled drugs and precursor chemicals licensing fees information for individuals and companies.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).